USPTO 2015–2025 USPTO PatentsView US Corporation

Salk Institute for Biological Studies

USPTO PatentsView assignee record - 109 granted patents across 21 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Salk ranks #3,406 of 49,997 tracked US assignees by granted-patent volume, with 109 patents across 21 technology areas.

#3,406
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.5/100)
20.6
avg claims per patent
+19%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R3406 · US Corporation #3,406 · 109 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-DENSE · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MID 109 grants
  • TOP-DECILE #3,406/49,997
  • PHOTO-FINISH SIG Technology
  • CPC-FOCUS A61P · 21 areas
  • INNOV-PAR 48.5/100
  • CLAIMS-DENSE 20.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +19% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: SIG Technology AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Salk

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Salk's Innovation Score is 48.5/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Salk's grants concentrate

Salk Institute for Biological Studies is a focused PatentsView assignee: 21 CPC subclasses with 55% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2020 (17 grants) versus a trough of 4 in 2024. By volume, Salk sits between SIG Technology AG and Toshiba Digital Solutions Corporation.

Salk's three-year grant acceleration

From 2019–2021 to 2022–2024, Salk Institute for Biological Studies moved from 45 to 25 grants (0.56x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,557. See the growth leaderboard.

Who files at Salk's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Salk holds 109 patents at rank #3,412, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Salk

By rank, the assignees closest to #3,412 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Salk's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Salk, neither rank-band nor same-CPC leaders (those blocks stay above).

Salk's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20152016201720182019202020212022202320242025 6
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Salk Institute for Biological Studies patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 11 10.1%
2016 5 4.6%
2017 5 4.6%
2018 12 11.0%
2019 14 12.8%
2020 17 15.6%
2021 14 12.8%
2022 12 11.0%
2023 9 8.3%
2024 4 3.7%
2025partial year 6 5.5%

Where it ranks

Overall rank by patents

#3,406

of 49,997 tracked assignees

Innovation Score

48.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Salk Institute for Biological Studies's patent record in context - here's where to go next.

  • Salk Institute for Biological Studies's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 55% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #3,406 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Salk Institute for Biological Studies against SIG Technology AG, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.